Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

Market Cap	5.88B
Revenue (ttm)	1.15B
Net Income (ttm)	345.39M
Shares Out	428.49M
EPS (ttm)	0.81
PE Ratio	16.94
Forward PE	15.24
Dividend	0.28 (2.04%)
Ex-Dividend Date	May 6, 2024

Volume	4,599,797
Average Volume	7,645,457
Open	13.86
Previous Close	13.83
Day's Range	13.65 - 13.94
52-Week Range	12.27 - 21.10
Beta	0.47
RSI	38.34
Earnings Date	Apr 11, 2025

About SHA:688389

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well as offer...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688389

Financial Performance

In 2024, SHA:688389's revenue was 1.15 billion, an increase of 0.20% compared to the previous year's 1.15 billion. Earnings were 345.39 million, an increase of 5.12%.